MX9603045A - Antagonistas de los receptores endoteliales. - Google Patents

Antagonistas de los receptores endoteliales.

Info

Publication number
MX9603045A
MX9603045A MX9603045A MX9603045A MX9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A
Authority
MX
Mexico
Prior art keywords
receptor antagonists
endothelial receptor
endothelial
salts
show
Prior art date
Application number
MX9603045A
Other languages
English (en)
Inventor
Mathias Osswald
Dieter Dorsch
Werner Mederski
Claudia Wilm
Claus J Schmitges
Maria Christadler
Original Assignee
Merck Patent Gmbh
Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Haftung filed Critical Merck Patent Gmbh
Publication of MX9603045A publication Critical patent/MX9603045A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nuevos compuestos de la formula I (Ver Formula) donde -Y-Z-, R1, R2, R3, R4, R5 y X tienen los significados indicados en la reivindicacion 1, y las sales, de estos compuestos, presentan propiedades antagonistas de los receptores de endotelina.
MX9603045A 1995-07-28 1996-07-26 Antagonistas de los receptores endoteliales. MX9603045A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19527568A DE19527568A1 (de) 1995-07-28 1995-07-28 Endothelin-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
MX9603045A true MX9603045A (es) 1997-01-31

Family

ID=7767990

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603045A MX9603045A (es) 1995-07-28 1996-07-26 Antagonistas de los receptores endoteliales.

Country Status (16)

Country Link
US (1) US5700807A (es)
EP (1) EP0755934A1 (es)
JP (1) JPH0940678A (es)
KR (1) KR970006305A (es)
AU (1) AU6060796A (es)
BR (1) BR9603164A (es)
CA (1) CA2182156A1 (es)
CZ (1) CZ219796A3 (es)
DE (1) DE19527568A1 (es)
HU (1) HUP9602054A3 (es)
MX (1) MX9603045A (es)
NO (1) NO963131L (es)
PL (1) PL315422A1 (es)
SK (1) SK92496A3 (es)
TW (1) TW367328B (es)
ZA (1) ZA966399B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291442B1 (en) 1998-02-03 2001-09-18 The General Hospital Corporation Pharmacological modulators of voltage-gated potassium ion channels
IL125659A (en) † 1998-08-05 2002-09-12 Cadent Ltd Method and device for three-dimensional simulation of a structure
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2002351412B2 (en) 2001-12-21 2010-05-20 Exelixis Patent Company Llc Modulators of LXR
AU2003215380B2 (en) * 2002-02-22 2008-10-02 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
BRPI0413923A (pt) * 2003-08-29 2006-11-07 Ono Pharmaceutical Co composto capaz de ligar o receptor de s1p e uso farmacêutico do mesmo
WO2015088564A1 (en) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
PL176250B1 (pl) 1991-11-05 1999-05-31 Smithkline Beecham Corp Sposób wytwarzania pochodnych indanu
ZA939516B (en) 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
EP0617001B1 (en) 1993-03-19 2000-01-26 Merck & Co. Inc. Phenoxyphenylacetic acid derivatives
WO1995033748A1 (en) * 1994-06-09 1995-12-14 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
AU6060796A (en) 1997-02-06
HU9602054D0 (en) 1996-09-30
SK92496A3 (en) 1997-07-09
CA2182156A1 (en) 1997-01-29
ZA966399B (en) 1997-02-19
JPH0940678A (ja) 1997-02-10
PL315422A1 (en) 1997-02-03
TW367328B (en) 1999-08-21
EP0755934A1 (en) 1997-01-29
NO963131L (no) 1997-01-29
HUP9602054A3 (en) 1998-07-28
BR9603164A (pt) 1998-05-05
CZ219796A3 (en) 1997-02-12
NO963131D0 (no) 1996-07-26
DE19527568A1 (de) 1997-01-30
KR970006305A (ko) 1997-02-19
US5700807A (en) 1997-12-23
HUP9602054A2 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
SG45486A1 (en) Pyrimidinedione pyrimidinetrione truazubeduione tetrahydro-quinazolinedione derivatives as alpha 1 adrenergic receptor antagonists
NZ307625A (en) 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
HUT70441A (en) Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties and pharmaceutical compositions comprising them
MA22758A1 (fr) Antagonistes des recepteurs d'endotheline
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
FI920217A7 (fi) Angiotensiini II reseptoria salpaavia 2,3,6-substituoituja kinatsolinoneja
MX9805253A (es) Antagonistas del receptor de vitronectina.
MY129596A (en) Quinoline derivatives as tachykinin nk3 receptor antagonists
HU9503402D0 (en) Neurokinin receptor antagonists
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
ZA9610736B (en) 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
MA23172A1 (fr) Antagonistes de recepteurs d'endotheline .
IL123112A0 (en) Piperazino derivatives as neurokinin antagonist
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
BG102589A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
FI973221L (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
EP0714295A4 (es)
AU9069191A (en) Use of angiotensin ii receptor antagonists in the prevention of restinosis
BG103502A (en) Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists
EP1246619A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS